Title : Severe acute liver injury associated with lumiracoxib.

Pub. Date : 2012 Jun

PMID : 22142375






1 Functional Relationships(s)
Download
Sentence
Compound Name
Protein Name
Organism
1 BACKGROUND AND AIM: Significant elevations in liver transaminases were noted in some patients during pre-marketing clinical trials with lumiracoxib, a selective COX-2 inhibitor. lumiracoxib mitochondrially encoded cytochrome c oxidase II Homo sapiens